There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology
Vas Narasimhan, CEO Of Novartis: Transforming Standards Of Patient Care - Outside Lens
Agenda · Total Health · Chicago, October 19-20, 2022
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Leaders with Lacqua: Vasant Narasimhan, Novartis CEO - YouTube
Vasant Narasimhan | Longevity Leaders | RadialReport
Amazon.com: Vasant Narasimhan: Books
Johnson & Johnson chief figures Amazon could shake up pharma's distribution, rebates and more | Fierce Pharma
Novartis says all options open on Sandoz after private equity interest emerges - Jnews
China Lost, Jeff Bezos Goes Big on India: Foreign Media | Technology News
A Year In, Novartis' Boss Faces The World
CNBC Halftime Report on Twitter: "Today on Halftime, don't miss @MegTirrell's #CNBCExclusive interview with Novartis CEO @VasNarasimhan! #JPM21 https://t.co/kmvOe2V4WJ" / Twitter
Narasimhan's Culture Club On Song At Novartis :: In Vivo
Vas Narasimhan, CEO Of Novartis: Transforming The Organisation - Outside Lens
Vas Narasimhan at the 2019 One Young World Summit - Human Engineers
Novartis to acquire US-based cancer drugmaker Endocyte for $2.1 billion | Business Standard News
Speakers · Total Health · Chicago, October 19-20, 2022
Novartis to limit M&A spend to 5% of market value | Financial Times
Novartis CEO says U.S. rebate plan will return cash to patients | Reuters
Novartis CEO Cautions on Efficacy of Trump-Touted Covid-19 Treatment - TheStreet
Committed to growing over 4% through 2026, says Novartis CEO
Novartis agrees $9.7bn deal for US cholesterol drugmaker | Financial Times
Digital transformation in the life sciences supply chain – show me the data | Kinaxis
